Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the history and v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:41:39.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The study record history shows the addition of revision v3.4.3 and the deletion of revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:28.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    An addition shows Revision: v3.4.2 in the history. A government-funding lapse notice and the entry for Revision: v3.4.1 were removed from the history.
    Difference
    0.8%
    Check dated 2026-02-11T14:00:20.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and operating status (cc.nih.gov). Updated the record history to Revision: v3.4.1, replacing the previous v3.4.0 entry.
    Difference
    0.8%
    Check dated 2026-02-04T10:18:49.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The history view now includes a glossary toggle and color-coded diffs (green for additions, red for deletions); release notes such as No FEAR Act Data and Revision: v3.4.0 are displayed as part of the changes.
    Difference
    1%
    Check dated 2026-01-28T06:09:44.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    A new history entry for Revision: v3.3.4 was added after Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T02:04:49.000Z thumbnail image

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.